James B. Tananbaum - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of FS Development Corp (FSDC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of FS Development Corp (FSDC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

FS Development Corp (FSDC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in 10x Genomics Inc (TXG). Other recent insider transactions involving 10x Genomics Inc (TXG) include a net sale of 90,937 shares made by Serge Saxonov , a net sale of 36,912 shares made by Benjamin J. Hindson , and a net sale of 9,758 shares made by Justin J. Mcanear .

In summary, during the past 3 months, insiders sold 12,959 shares of 10x Genomics Inc (TXG) in total and bought 0 shares, with a net sale of 12,959 shares. During the past 18 months, 208,804 shares of 10x Genomics Inc (TXG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 208,804 shares.

10x Genomics Inc (TXG)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 12,645 shares made by Laura Sepp-lorenzino , and a net sale of 2,397 shares made by Muna Bhanji .

In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made 1 insider transaction in Kinnate Biopharma Inc (KNTE) with a net purchase of 1,780,000. Other recent insider transactions involving Kinnate Biopharma Inc (KNTE) include a net purchase of 2,866,100 shares made by Carl L Gordon , a net purchase of 2,866,100 shares made by Orbimed Advisors Llc , and a net purchase of 1,780,000 shares made by Foresite Capital Fund Iv, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 9,292,200 shares were bought by its insiders, resulting in a net purchase of 9,292,200 shares.

Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in Quantum-Si Inc (QSI). Other recent insider transactions involving Quantum-Si Inc (QSI) include a net purchase of 30,000 shares made by Christian Lapointe , a net sale of 89,000 shares made by Kevin Rakin , and a net purchase of 50,000 shares made by Jeffry R. Keyes .

In summary, during the past 3 months, insiders sold 0 shares of Quantum-Si Inc (QSI) in total and bought 85,000 shares, with a net purchase of 85,000 shares. During the past 18 months, 89,000 shares of Quantum-Si Inc (QSI) were sold and 105,000 shares were bought by its insiders, resulting in a net purchase of 16,000 shares.

Quantum-Si Inc (QSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net sale of 1,106,612 shares made by Atlas Venture Fund X, L.p. , a net sale of 297,652 shares made by Kevin Bitterman , and a net sale of 20,634 shares made by Joanne Bryce .

In summary, during the past 3 months, insiders sold 28,717 shares of Disc Medicine Inc (IRON) in total and bought 0 shares, with a net sale of 28,717 shares. During the past 18 months, 3,899,666 shares of Disc Medicine Inc (IRON) were sold and 652,175 shares were bought by its insiders, resulting in a net sale of 3,247,491 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in Pardes Biosciences Inc (PRDS). Other recent insider transactions involving Pardes Biosciences Inc (PRDS) include a net purchase of 50,000 shares made by Thomas G Wiggans , a net purchase of 773,952 shares made by Foresite Capital Fund V, L.p. , and a net purchase of 773,952 shares made by Foresite Capital Opportunity Fund V, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Pardes Biosciences Inc (PRDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pardes Biosciences Inc (PRDS) were sold and 2,256,324 shares were bought by its insiders, resulting in a net purchase of 2,256,324 shares.

Pardes Biosciences Inc (PRDS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James B. Tananbaum made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 1,200,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 671,932 shares made by Carl L Gordon , and a net purchase of 671,932 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 2,557,866 shares were bought by its insiders, resulting in a net purchase of 2,557,866 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.